share_log

热景生物(688068.SH)发预减,预计2023年净利2400万元到3600万元,同比大跌96.19%到97.46%

Hejing Biotech (688068.SH) issued a pre-cut. Net profit is expected to be 24 million yuan to 36 million yuan in 2023, a sharp drop of 96.19% to 97.46% year on year

Zhitong Finance ·  Jan 30 09:09

Hot View Biotech (688068.SH) released its 2023 annual performance forecast and is expected to achieve ownership in 2023...

According to Zhitong Finance App News, Hot View Biotech (688068.SH) released its 2023 annual performance forecast. It is expected to achieve net profit of 24 million yuan to 36 million yuan attributable to the owner of the parent company in 2023. Compared with the same period last year (statutory disclosure data), it will decrease by 90,8736,600 yuan to 920.7366 million yuan, a year-on-year decrease of 96.19% to 97.46%.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment